实用老年医学 ›› 2021, Vol. 35 ›› Issue (7): 758-761.doi: 10.3969/j.issn.1003-9198.2021.07.026
詹莹莹, 陈锐, 刘琳妍, 葛健康
收稿日期:2020-09-05
出版日期:2021-07-20
发布日期:2021-08-02
通讯作者:
陈锐,Email: chenrui2010@126.com
Received:2020-09-05
Online:2021-07-20
Published:2021-08-02
中图分类号:
詹莹莹, 陈锐, 刘琳妍, 葛健康. 肌少症与慢性心力衰竭的相关研究进展[J]. 实用老年医学, 2021, 35(7): 758-761.
| [1] CRUZ-JENTOFT A J, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis [J]. Age Ageing, 2019, 48(1):16-31. [2] 薛刚, 吴永华, 王敏红, 等. 老年慢性心力衰竭病人并发肌少症的相关因素分析[J]. 实用老年学杂志, 2020, 34(12):1266-1269. [3] JOSIAK K, JANKOWSKAE A, PIEPOLI M F, et al. Skeletal myopathy in patients with chronic heart failure: Signifificance of anabolic-androgenic hormones [J]. Cachexia Sarcopenia Muscle, 2014, 5(4): 287-296. [4] DELAFONTAINE P, YOSHIDA T. The renin-angiotensin system and the biology of skeletal muscle: mechanisms of muscle wasting in chronic disease states [J]. Trans Am Clin Climatol Assoc, 2016, 127:245-258. [5] ANTINOZZI C, MARAMPON F, CORINALDESI C, et al. Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells [J]. J Endocrinol Invest, 2017, 40(10):1133-1143. [6] MÜLLERT D, NOGUEIRAS R, ANDERMANN M L, et al. Ghrelin [J]. Mol Metab, 2015, 4(6):437-460. [7] RONG Y D, BIAN A L, HU H Y. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10[J]. BMC Geriatr, 2018, 18(1):308. [8] LIGUORI I, RUSSO G, CURCIO F, et al. Oxidative stress, aging, and diseases [J]. Clin Interv Aging, 2018, 26(13):757-772. [9] HU J, CHENG P, HUANG G Y, et al. Effects of Xin-Ji-Er-Kang on heart failure induced by myocardial infarction: role of inflammation, oxidative stress and endothelial dysfunction [J]. Phytomedicine, 2018, 42:245-257. [10] SAITOH M, ISHIDA J, DOEHNER W, et al. Sarcopenia, cachexia, and muscle performance in heart failure review update 2016 [J]. Int J Cardiol, 2017, 238:5-11. [11] SAKUMA K, AOI W, YAMAGUCHI A. Molecular mechanism of sarcopenia and cachexia: recent research advances [J]. Pflugers Arch, 2017, 469(5/6):573-591. [12] GHOSH R, PATTISON J S. Macroautophagy and chaperone-mediated autophagy in heart failure: the known and the unknown [J]. Oxid Med Cell Longev, 2018, 2018:8602041. [13] TOWER J. Programmed cell death in aging[J]. Ageing Res Rev, 2015, 23(Pt A):90-100. [14] PHILIPPOU A, XANTHIS D, CHRYSSANTHOPΟULOS C, et al. Heart failure-induced skeletal muscle wasting [J]. Current Heart Failure Reports, 2020, 17(5):299-308. [15] ILHAN B, BAHAT G, ERDOGAN C, et al. Anorexia is independently associated with decreased muscle mass and strength in community dwelling older adults [J]. Health Aging, 2019, 23(2):202-206. [16] 周晓宁, 许金海, 王国栋, 等. 肌少症治疗[J]. 中华骨质疏松和骨矿盐疾病杂志, 2020, 13(3):272-279. [17] COKER R H, HAYS N P, WILLIAMS R H, et al. Bed rest worsens impairments in fat and glucose metabolism in older, overweight adults [J]. J Gerontol A Biol Sci Med Sci, 2014, 69(3):363-370. [18] MAHMASSANI Z S, REIDY P T, MCKENZIE A I, et al. Age-dependent skeletal muscle transcriptome response to bed rest-induced atrophy[J]. J Appl Physiol, 2019, 126(4):894-902. [19] NIEMEIJER V M, SNIJDERS T, VERDIJK L B, et al. Skeletal muscle fiber characteristics in patients with chronic heart failure: impact of disease severity and relation with muscle oxygenation during exercise[J]. J Appl Physiol, 2018.DOI: 10.1152/japplphysiol. 00057.2018. [20] DOS SANTOSM R, SAITOH M, EBNER N, et al. Sarcopenia and endothelial function in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating HF (SICA-HF) [J]. Am Med Dir Assoc, 2017, 18(3):240-245. [21] ZHOUL S, XUL J, WANG X Q, et al. Effect of angiotensin-converting enzyme inhibitors on physical function in elderly subjects: a systematic review and meta-analysis [J]. Drugs Aging, 2015, 32(9):727-735. [22] BAND M M, SUMUKADAS D, STRUTHERS A D. Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial [J]. Trials, 2018, 19(1):6. [23] LAINSCAK M, KEBER I, ANKERS D. Body composition changes in patients with systolic heart failure treated with beta blockers: A pilot study [J]. Int J Cardiol, 2006, 106(3): 319-322. [24] CVAN TROBEC K, GRABNAR I, KEREC KOS M. Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study[J]. Eur J Clin Pharmacol, 2016, 72(7):813-822. [25] BURTON L A, MCMURDO M E, STRUTHERS A D, et al. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people? [J]. Clin Endocrinol: Oxf, 2011, 75(6):725-729. [26] ARRIETA H, HERVÁS G, REZOLA-PARDO C. Serum myostatin levels are higher in fitter, more active, and non-frail long-term nursing home residents and increase after a physical exercise Intervention [J]. Gerontology, 2019, 65(3):229-239. [27] FERNHALL B. Long-term aerobic exercise maintains peak VO(2), improves quality of life, and reduces hospitalisations and mortality in patients with heart failure [J]. J Physiother, 2013, 59(1):56. [28] EBNER N, VON HAEHLING S. Cachexia and sarcopenia in chronic heart failure: change in muscle strength and muscle structure [J]. Internist: Berl, 2018, 59(5):439-444. [29] DUPONT J, DEDEYNE L, DALLE S, et al. The role of omega-3 in the prevention and treatment of sarcopenia [J]. Aging Clin Exp Res, 2019, 31(6):825-836. [30] D'AMORE C, MARSICO F, PARENTE A, et al. Vitamin D deficiency and clinical outcome in patients with chronic heart failure [J]. Nutr Metab Cardiovasc Dis, 2017, 27(10):837-849. |
| [1] | 刘瑾, 黄艳秋, 朱毅, 卓莉莉. 沙库巴曲缬沙坦钠对老年慢性心力衰竭病人的影响[J]. 实用老年医学, 2024, 38(10): 1030-1033. |
| [2] | 刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437. |
| [3] | 程清, 徐艳, 陈国飞, 邓心悦. 血清血管紧张素Ⅱ和一氧化氮水平与老年慢性心力衰竭病人认知功能障碍的相关性[J]. 实用老年医学, 2024, 38(2): 132-135. |
| [4] | 任丽艳. 老年心力衰竭病人血清胆碱酯酶水平与心室重塑的相关性研究[J]. 实用老年医学, 2023, 37(12): 1238-1241. |
| [5] | 刘离香, 刘永铭. 巨噬细胞在心力衰竭中的作用及相关治疗研究进展[J]. 实用老年医学, 2023, 37(12): 1270-1273. |
| [6] | 陆昊, 邓慧, 王春, 戴阳, 王芹, 王青. 老年慢性心力衰竭稳定期病人心肺功能、运动耐力特征及NT-proBNP和TNT分析[J]. 实用老年医学, 2023, 37(11): 1138-1142. |
| [7] | 李善淑, 吕逸宁, 宫慧敏, 张改改. 沙库巴曲缬沙坦治疗老年慢性心力衰竭病人效果的Meta分析[J]. 实用老年医学, 2023, 37(10): 1023-1026. |
| [8] | 胡静雯, 姜婉莹, 霍俊宇, 王岚, 王骁智. 中低剂量沙库巴曲缬沙坦对射血分数降低的老年心力衰竭病人心室重构和再住院率的影响[J]. 实用老年医学, 2023, 37(8): 828-833. |
| [9] | 杨少琦, 杨洋, 邓丽娜, 翟志欣. 系统免疫炎症指数对老年射血分数减低型心力衰竭病人下肢深静脉血栓形成的预测价值[J]. 实用老年医学, 2023, 37(7): 695-699. |
| [10] | 马洪珍, 周军, 高飞, 郭露露, 柏云, 张涛. NT-proBNP联合可溶性ST2蛋白对老年慢性肾脏病合并心力衰竭病人的诊断价值[J]. 实用老年医学, 2023, 37(5): 459-463. |
| [11] | 王春燕, 宋亚玲, 任海霞. APRI与老年射血分数保留心力衰竭病人右心功能和预后的相关性[J]. 实用老年医学, 2023, 37(4): 382-385. |
| [12] | 程忠良, 凌燕, 梁晓辉. CK-MB、BNP及纤维蛋白原/白蛋白比值对老年慢性心力衰竭病人再入院率的预测价值[J]. 实用老年医学, 2023, 37(2): 168-172. |
| [13] | 李军, 吕振, 李蓓蓓. 金属蛋白酶组织抑制因子对老年慢性心力衰竭病人院内死亡的预测价值[J]. 实用老年医学, 2021, 35(11): 1162-1165. |
| [14] | 曹雅茹, 姜苏蓉, 王璎瑛, 王小艳, 许迪, 郭妍. 老年射血分数保留心力衰竭病人超声心动图相关参数的研究分析[J]. 实用老年医学, 2021, 35(10): 1049-1053. |
| [15] | 冯晓红, 邬真力. 半乳糖凝集素3对心力衰竭病人的诊断及预后价值[J]. 实用老年医学, 2021, 35(10): 1084-1086. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
|
